Literature DB >> 15379960

Production of Heymann nephritis by a chemically modified renal antigen.

Arpad Z Barabas1, Chad D Cole, Arpad D Barabas, Rene Lafreniere.   

Abstract

An autoimmune kidney disease morphologically and functionally similar to Heymann nephritis (HN) was induced in mature male Sprague Dawley rats by repeated weekly IP injections of a chemically modified azo sonicated ultracentrifuged (u/c) rat kidney fraction 3 (rKF3) antigen in an aqueous medium. The experiment was terminated 15 weeks after the first injection of the chemically altered antigen. Serum samples collected and analysed by an indirect fluorescent antibody test on normal rat kidney sections during the course of the experiment showed a gradual rise in circulating pathogenic autoantibodies directed against the proximal tubular brush border regions. Proteinuria was present and significantly increased in the urine of two of eight rats. The arising immune-complex glomerulonephritis (ICGN) revealed typical HN kidney disease lesions in 70% of the rats in histological, direct fluorescent antibody and electron-microscopical examinations. Control rats injected similarly with the an unmodified version of the same antigen did not develop the HN-characteristic morphological and functional changes. To our knowledge, this is the first time that the autoimmune kidney disease designated as an active HN has been produced by the administration of a chemically altered renal antigen in an aqueous solution and not by the usual presentation of the nephritogenic renal antigen in an adjuvant.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379960      PMCID: PMC2517528          DOI: 10.1111/j.0959-9673.2004.00389.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  53 in total

1.  Immortalized rat proximal tubule cells produce membrane bound and soluble megalin.

Authors:  F F Jung; D R Bachinsky; S S Tang; G Zheng; D Diamant; L Haveran; R T McCluskey; J R Ingelfinger
Journal:  Kidney Int       Date:  1998-02       Impact factor: 10.612

Review 2.  CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.

Authors:  P Casali; A L Notkins
Journal:  Immunol Today       Date:  1989-11

3.  Experimental glomerulonephritis.

Authors:  D J Salant; A V Cybulsky
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

4.  Formation of immune deposits and disease.

Authors:  G Andres; J R Brentjens; P R Caldwell; G Camussi; S Matsuo
Journal:  Lab Invest       Date:  1986-11       Impact factor: 5.662

5.  Auto-immune nephritis in rats.

Authors:  A Z Barabas; R Lannigan
Journal:  J Pathol       Date:  1969-03       Impact factor: 7.996

6.  Drug-induced lupus. Genetic, clinical, and laboratory features.

Authors:  M C Totoritis; R L Rubin
Journal:  Postgrad Med       Date:  1985-09-01       Impact factor: 3.840

7.  Characterization of the antigen (gp600) of Heymann nephritis.

Authors:  S P Makker; A K Singh
Journal:  Lab Invest       Date:  1984-03       Impact factor: 5.662

8.  Characterization of antigens and antibody specificities involved in Heymann nephritis.

Authors:  K Kamata; L G Baird; M E Erikson; A B Collins; R T McCluskey
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

9.  Effect of reimmunization with Fx1A late in the course of Heymann nephritis.

Authors:  B Noble; J B Van Liew; J R Brentjens; G A Andres
Journal:  Lab Invest       Date:  1982-11       Impact factor: 5.662

10.  Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen.

Authors:  T S Edgington; R J Glassock; F J Dixon
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Regaining tolerance to a self-antigen by the modified vaccination technique.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Rene Lafreniere; Donald Mackay Weir
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

2.  Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-12       Impact factor: 1.925

Review 3.  Antibody-initiated beneficial and harmful immune responses.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Rene Lafreniere
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

4.  Tolerance, loss of tolerance and regaining tolerance to self by immune-mediated events.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Richard Milton Graeff; Rene Lafreniere; Donald Mackay Weir
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

5.  Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Biologics       Date:  2007-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.